Influence of Tart Cherry Juice Intervention on Vascular Function

April 8, 2021 updated by: Northumbria University

Influence of Tart Cherry Juice Intervention on Vascular Function and the Urinary Metabolite; a Preliminary Study to Inform Study Design

Diets containing fruit rich in anthocyanins have been shown (in meta-analyses) to be beneficial for health, but intervention trials have shown inconsistent results. In this preliminary study we want to investigate the influence of a tart-cherry juice intervention on vascular function and explore metabolite profiles that may offer insight into their mechanism of action

Study Overview

Detailed Description

Cardiovascular disease (CVD) is the primary cause of morbidity and mortality. Tart cherries (TC) can positively impact major risk factors of CVD, activities thought to be related to their phytochemical content. However, data from human trials is less clear. TC have been shown to reduce systolic blood pressure (SBP) after acute, short-term and chronic intake, and to improve vascular dysfunction, presumably due to their antioxidant and anti-inflammatory activities. Other studies have not shown benefits of TC on SBP or vascular function and studies are difficult to interpret with different populations, dosing and durations being used as well as a lack of understanding for any underlying mechanisms. To account for the latter, the use of metabolomics has become increasingly popular in nutritional research. Therefore, the aim of this preliminary study was to characterise the effects of TC supplementation on vascular function with a 4-week intervention and explore if metabolomics can provide mechanistic evidence and this will inform for future chronic studies with TC juice.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Newcastle Upon Tyne, United Kingdom, NE1 7ST
        • Northumberland Building

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged 19-40
  • no diagnosed issues with the ability to consume fruit juice
  • no known food intolerances to fruits

Exclusion Criteria:

  • participants that are cigarette smokers
  • participants diagnosed with hypertension
  • participants diagnosed with any form of cardiometabolic diseases
  • participants that require any prescribed prescriptions excluding the contraceptive pill
  • participants that are regular consumers of cherries (>100 g/d)
  • participants that consume any antioxidant supplements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
Participants supplied with 30 ml of a low fruit (<1%) cordial mixed with maltodextrin and protein diluted in 100 ml water twice daily, once in the morning and evening.
A tart cherry juice placebo
Experimental: Cherry juice
Participants supplied with 30 ml of a tart cherry juice concentrate (CherryActive, United Kingdom; (containing 36.8 mg of anthocyanins) diluted in 100 ml of water twice daily, once in the morning and evening.
A tart cherry juice intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Systolic and diastolic blood pressure
Time Frame: Change in blood pressure following 4 weeks intervention
Measurement of systolic and diastolic blood pressure before and after the intervention
Change in blood pressure following 4 weeks intervention
Arterial pulse wave velocity
Time Frame: Change in pulse wave velocity following 4 weeks intervention
Measurement of pulse wave velocity before and after the intervention
Change in pulse wave velocity following 4 weeks intervention
Digital volume pulse
Time Frame: Change in digital volume pulse following 4 weeks intervention
Measurement of digital volume pulse before and after the intervention
Change in digital volume pulse following 4 weeks intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolomics
Time Frame: Changes to urinary metabolite profiles following 4 weeks intervention
Ion intensities of ca 5000 metabolites in urine samples before and after the intervention
Changes to urinary metabolite profiles following 4 weeks intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

April 6, 2021

First Submitted That Met QC Criteria

April 8, 2021

First Posted (Actual)

April 9, 2021

Study Record Updates

Last Update Posted (Actual)

April 9, 2021

Last Update Submitted That Met QC Criteria

April 8, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • lucymurray2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Research data will be shared on request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Disturbance

Clinical Trials on Placebo

3
Subscribe